Acadia Healthcare Co. (NASDAQ:ACHC)’s share price rose 2.1% during trading on Monday . The company traded as high as $54.85 and last traded at $54.27, with a volume of 556,519 shares traded. The stock had previously closed at $53.15.

ACHC has been the subject of a number of analyst reports. Jefferies Group reiterated a “buy” rating and set a $85.00 target price on shares of Acadia Healthcare in a research note on Monday, June 27th. Leerink Swann reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Monday, May 2nd. Zacks Investment Research upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $71.00 target price for the company in a research note on Monday, May 2nd. Cantor Fitzgerald reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Friday, April 29th. Finally, Mizuho boosted their target price on shares of Acadia Healthcare from $66.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, April 29th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the stock. Acadia Healthcare currently has an average rating of “Buy” and an average target price of $79.33.

The company’s 50 day moving average price is $57.30 and its 200 day moving average price is $57.47. The firm has a market capitalization of $4.70 billion and a price-to-earnings ratio of 31.99.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, April 28th. The company reported $0.55 EPS for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.01. The business earned $616.80 million during the quarter, compared to analysts’ expectations of $612.77 million. The business’s revenue was up 68.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.43 EPS. Equities analysts anticipate that Acadia Healthcare Co. will post $2.82 EPS for the current fiscal year.

Other large investors have recently added to or reduced their stakes in the company. US Bancorp DE increased its stake in Acadia Healthcare by 29.1% in the fourth quarter. US Bancorp DE now owns 23,508 shares of the company’s stock valued at $1,469,000 after buying an additional 5,298 shares during the period. Trexquant Investment LP increased its stake in Acadia Healthcare by 93.3% in the fourth quarter. Trexquant Investment LP now owns 27,300 shares of the company’s stock valued at $1,705,000 after buying an additional 13,176 shares during the period. State Board of Administration of Florida Retirement System increased its stake in Acadia Healthcare by 8.5% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 33,247 shares of the company’s stock valued at $2,077,000 after buying an additional 2,596 shares during the period. BOKF NA increased its stake in Acadia Healthcare by 21.3% in the fourth quarter. BOKF NA now owns 49,771 shares of the company’s stock valued at $3,109,000 after buying an additional 8,752 shares during the period. Finally, Rhumbline Advisers increased its stake in Acadia Healthcare by 6.1% in the fourth quarter. Rhumbline Advisers now owns 53,198 shares of the company’s stock valued at $3,323,000 after buying an additional 3,045 shares during the period.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.